Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Diabetes mellitus in dogs shares many characteristics with the human type 1 disease and virtually all diabetic dogs require insulin therapy to control hyperglycaemia. Insulin deficiency is suspected to result from immune-mediated destruction of pancreatic beta cells in some cases. Human patients suf...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1797072137391964160 |
|---|---|
| author | Davison, L Weenink, S Christie, MR Herrtage, M Catchpole, B |
| author_facet | Davison, L Weenink, S Christie, MR Herrtage, M Catchpole, B |
| author_sort | Davison, L |
| collection | OXFORD |
| description | Diabetes mellitus in dogs shares many characteristics with the human type 1 disease and virtually all diabetic dogs require insulin therapy to control hyperglycaemia. Insulin deficiency is suspected to result from immune-mediated destruction of pancreatic beta cells in some cases. Human patients suffering from Type 1A (immune-mediated) diabetes or latent autoimmune diabetes of the adult (LADA) demonstrate circulating autoantibodies against the 65kDa isoform of glutamic acid decarboxylase (GAD65) and/or insulinoma antigen-2 (IA-2). The aims of the current study were to develop radio-immunoassays to detect serum antibodies against recombinant canine GAD65 and IA-2 and to identify diabetic dogs showing serological evidence of autoreactivity to these pancreatic beta cell antigens. Canine GAD65 and the 3' end of IA-2 (coding for amino acids 771-979 of the intracellular domain) were amplified by PCR from cDNA prepared from canine insulinoma tissue and cloned into the pCRII vector. The canine sequences were later confirmed by identifying GAD2 and PTPRN genes from the dog genome assembly. Recombinant (35)S-methionine-radiolabelled canine GAD65 and IA-2 (771-979) proteins were used in radio-immunoprecipitation assays to screen sera from 30 newly diagnosed diabetic dogs and 30 control dogs. Four of 30 canine diabetic patients had significant GAD65 autoreactivity (p<0.01) compared to controls and 3 dogs were positive for autoantibodies to IA-2 (771-979). Two diabetic dogs showed dual autoantigen reactivity. These preliminary data indicate that serological reactivity to GAD65 and IA-2 is present in a proportion of diabetic dogs and suggests that, in some cases, canine diabetes is associated with an autoimmune response to these antigens. |
| first_indexed | 2024-03-06T23:03:20Z |
| format | Journal article |
| id | oxford-uuid:62ede5c9-3831-46bb-91bb-07e09084c6dc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:03:20Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:62ede5c9-3831-46bb-91bb-07e09084c6dc2022-03-26T18:09:30ZAutoantibodies to GAD65 and IA-2 in canine diabetes mellitus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:62ede5c9-3831-46bb-91bb-07e09084c6dcEnglishSymplectic Elements at Oxford2008Davison, LWeenink, SChristie, MRHerrtage, MCatchpole, BDiabetes mellitus in dogs shares many characteristics with the human type 1 disease and virtually all diabetic dogs require insulin therapy to control hyperglycaemia. Insulin deficiency is suspected to result from immune-mediated destruction of pancreatic beta cells in some cases. Human patients suffering from Type 1A (immune-mediated) diabetes or latent autoimmune diabetes of the adult (LADA) demonstrate circulating autoantibodies against the 65kDa isoform of glutamic acid decarboxylase (GAD65) and/or insulinoma antigen-2 (IA-2). The aims of the current study were to develop radio-immunoassays to detect serum antibodies against recombinant canine GAD65 and IA-2 and to identify diabetic dogs showing serological evidence of autoreactivity to these pancreatic beta cell antigens. Canine GAD65 and the 3' end of IA-2 (coding for amino acids 771-979 of the intracellular domain) were amplified by PCR from cDNA prepared from canine insulinoma tissue and cloned into the pCRII vector. The canine sequences were later confirmed by identifying GAD2 and PTPRN genes from the dog genome assembly. Recombinant (35)S-methionine-radiolabelled canine GAD65 and IA-2 (771-979) proteins were used in radio-immunoprecipitation assays to screen sera from 30 newly diagnosed diabetic dogs and 30 control dogs. Four of 30 canine diabetic patients had significant GAD65 autoreactivity (p<0.01) compared to controls and 3 dogs were positive for autoantibodies to IA-2 (771-979). Two diabetic dogs showed dual autoantigen reactivity. These preliminary data indicate that serological reactivity to GAD65 and IA-2 is present in a proportion of diabetic dogs and suggests that, in some cases, canine diabetes is associated with an autoimmune response to these antigens. |
| spellingShingle | Davison, L Weenink, S Christie, MR Herrtage, M Catchpole, B Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title | Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title_full | Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title_fullStr | Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title_full_unstemmed | Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title_short | Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. |
| title_sort | autoantibodies to gad65 and ia 2 in canine diabetes mellitus |
| work_keys_str_mv | AT davisonl autoantibodiestogad65andia2incaninediabetesmellitus AT weeninks autoantibodiestogad65andia2incaninediabetesmellitus AT christiemr autoantibodiestogad65andia2incaninediabetesmellitus AT herrtagem autoantibodiestogad65andia2incaninediabetesmellitus AT catchpoleb autoantibodiestogad65andia2incaninediabetesmellitus |